Last updated: July 17, 2026

Application No. 18/602,240

BINDING COMPETITORS FOR USE IN MACROPHILIN-BINDING PHARMACEUTICAL ASSAYS AND METHODS OF USE THEREOF

Non-Final OA

Filed

Mar 12, 2024

Priority

Nov 02, 2018 — provisional 62/754,913 +2 more

Examiner

SAEED, KAMAL A

Art Unit

1626

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Siemens Healthineers AG

OA Round

1 (Non-Final)

Interview Optional

— +9.6% interview lift. Interview lift (+9.6%) is below the 15.0% threshold. A written response is recommended.

Based on 1205 resolved cases, 2023–2026

Examiner Intelligence

SAEED, KAMAL A View full profile →

Grants 84% — above average

Career Allowance Rate

1010 granted / 1205 resolved

+23.8% vs TC avg

Moderate +10% lift

Without

With

+9.6%

Interview Lift

resolved cases with interview

Fast prosecutor

2y 0m

Avg Prosecution

16 currently pending

Career history

1227

Total Applications

across all art units

Statute-Specific Performance

§101

0.4%

-39.6% vs TC avg

§103

5.8%

-34.2% vs TC avg

§102

3.1%

-36.9% vs TC avg

§112

3.1%

-36.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1205 resolved cases

Prosecution Timeline

Mar 12, 2024

Application Filed

Mar 26, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/012,450

Patent 12679835

BENZOTHIAZINONE DERIVATIVE SUBSTITUTED WITH TRIFLUOROMETHYL AT 6-POSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF

2y 5m to grant Granted Jul 14, 2026

18/276,412

Patent 12678386

ORGANIC COMPOUNDS AS TRPM8 ACTIVATORS

2y 11m to grant Granted Jul 14, 2026

18/268,980

Patent 12673959

POLYSUBSTITUTED IMIDAZOLO[4,5-c][1,2]THIAZINE DERIVATIVE AND USE THEREOF

3y 0m to grant Granted Jul 07, 2026

18/274,093

Patent 12668576

PYRAZOLAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

2y 11m to grant Granted Jun 30, 2026

17/455,807

Patent 12662473

INHIBITORS FOR PROGRAMMED CELL NECROSIS AND PREPARATION METHOD THEREFOR AND USE THEREOF

4y 2m to grant Granted Jun 23, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

84%

Grant Probability

93%

With Interview (+9.6%)

2y 0m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1205 resolved cases by this examiner. Grant probability derived from career allowance rate.